Skip to content

RxSight, Inc. RXST Change in Other Assets

Change in Other Assets at other companies

LENSAR, Inc. logo
LENSAR, Inc.LNSR
$24K+110%
Schering-Plough logo
Schering-PloughSGP
$298K+1,046%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$357K+109%
Bausch + Lomb logo
Bausch + LombBLCO
$38M+245%
Glaukos logo
GlaukosGKOS
-$971K-825%

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Gross profit$23.5M-17.1%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%
Free cash flow-$11.7M-23.8%

Valuation

See full
Market cap$232.23M-56.8%
Enterprise value$225.49M-55.7%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Return on equity-17.1%+12.6pp
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Reported directly by RxSight, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s change in other assets?
RxSight, Inc. (RXST) reported change in other assets of -$120K in Q1 2026.
How has RxSight, Inc.'s change in other assets changed year-over-year?
RxSight, Inc.'s change in other assets increased by 52.8% year-over-year, from -$254K to -$120K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.